Myla Puyat
Financieel Directeur/CFO bij Auxogyn, Inc.
Actieve functies van Myla Puyat
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Hoofd Administratief Officier | 01-07-2014 | - |
Financieel Directeur/CFO | 01-07-2014 | - |
Loopbaan van Myla Puyat
Eerdere bekende functies van Myla Puyat
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PROGYNY, INC. | Hoofd Administratief Officier | 01-07-2014 | - |
Financieel Directeur/CFO | 01-07-2014 | - | |
ForteBio, Inc.
ForteBio, Inc. Medical SpecialtiesHealth Technology Pall ForteBio Corp. develops analytical systems that enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. The company was founded in October 2001 and is headquartered in Menlo Park, CA. | Hoofd Administratief Officier | - | - |
Financieel Directeur/CFO | - | - | |
GeneTrol Biotherapeutics, Inc. | Comptroller/Controller/Auditor | - | - |
Operationeel Directeur | - | - | |
Verinata Health, Inc.
Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Hoofd Administratief Officier | 11-08-2009 | 25-04-2013 |
Financieel Directeur/CFO | 11-08-2009 | - |
Opleiding van Myla Puyat
Santa Clara University | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Chief Administrative Officer | 4 |
Director of Finance/CFO | 4 |
Comptroller/Controller/Auditor | 1 |
Sectoraal
Health Technology | 3 |
Health Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PROGYNY, INC. | Commercial Services |
Bedrijven in privébezit | 4 |
---|---|
Verinata Health, Inc.
Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Health Services |
ForteBio, Inc.
ForteBio, Inc. Medical SpecialtiesHealth Technology Pall ForteBio Corp. develops analytical systems that enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. The company was founded in October 2001 and is headquartered in Menlo Park, CA. | Health Technology |
GeneTrol Biotherapeutics, Inc. | |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Health Technology |
- Beurs
- Insiders
- Myla Puyat
- Ervaring